Journal
JOURNAL OF MEDICAL VIROLOGY
Volume 93, Issue 12, Pages 6765-6777Publisher
WILEY
DOI: 10.1002/jmv.27270
Keywords
avidity; protective immunity; receptor-binding domain; recomLine SARS-CoV-2 IgG; SARS-CoV-2; vaccination
Categories
Funding
- Projekt DEAL
Ask authors/readers for more resources
The study confirmed incomplete avidity maturation of IgG in COVID-19 patients towards SARS-CoV-2 proteins, potentially hindering the establishment of herd immunity and facilitating secondary infections. In contrast, vaccination with BioNTech mRNA vaccine rapidly induced high avidity in SARS-CoV-2 naive individuals, emphasizing the importance of vaccination in promoting avidity maturation and immunity.
Avidity is defined as the binding strength of immunoglobulin G (IgG) toward its target epitope. Avidity is directly related to affinity, as both processes are determined by the best fit of IgG to epitopes. We confirm and extend data on incomplete avidity maturation of IgG toward severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleoprotein (NP), spike protein-1 (S1), and its receptor-binding domain (RBD) in coronavirus disease 2019 (COVID-19) patients. In SARS-CoV-2-infected individuals, an initial rise in avidity maturation was ending abruptly, leading to IgG of persistently low or intermediate avidity. Incomplete avidity maturation might facilitate secondary SARS-CoV-2 infections and thus prevent the establishment of herd immunity. Incomplete avidity maturation after infection with SARS-CoV-2 (with only 11.8% of cases showing finally IgG of high avidity, that is, an avidity index > 0.6) was contrasted by regular and rapid establishment of high avidity in SARS-CoV-2 naive individuals after two vaccination steps with the BioNTech messenger RNA (mRNA) Vaccine (78% of cases with high avidity). One vaccination step was not sufficient for induction of complete avidity maturation in vaccinated SARS-CoV-2 naive individuals, as it induced high avidity only in 2.9% of cases within 3 weeks. However, one vaccination step was sufficient to induce high avidity in individuals with previous SARS-CoV-2 infection.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available